KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Invested Capital (2016 - 2026)

Medtronic's Invested Capital history spans 13 years, with the latest figure at $49.2 billion for Q1 2026.

  • For Q1 2026, Invested Capital fell 5.86% year-over-year to $49.2 billion; the TTM value through Jan 2026 reached $49.2 billion, down 5.86%, while the annual FY2025 figure was $2.9 billion, 94.42% down from the prior year.
  • Invested Capital for Q1 2026 was $49.2 billion at Medtronic, down from $50.3 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $58.6 billion in Q3 2022 and bottomed at $865.0 million in Q1 2022.
  • The 5-year median for Invested Capital is $51.9 billion (2023), against an average of $47.0 billion.
  • The largest annual shift saw Invested Capital surged 6531.1% in 2023 before it plummeted 94.42% in 2025.
  • A 5-year view of Invested Capital shows it stood at $57.9 billion in 2022, then decreased by 8.52% to $53.0 billion in 2023, then dropped by 1.04% to $52.4 billion in 2024, then decreased by 4.12% to $50.3 billion in 2025, then fell by 2.19% to $49.2 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Invested Capital are $49.2 billion (Q1 2026), $50.3 billion (Q4 2025), and $50.6 billion (Q3 2025).